Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Capturing Patients' Perspectives on Medication Safety: The Development of a Patient-Centered Medication Safety Framework.

Giles SJ, Lewis PJ, Phipps DL, Mann F, Avery AJ, Ashcroft DM.

J Patient Saf. 2019 Mar 11. doi: 10.1097/PTS.0000000000000583. [Epub ahead of print]

PMID:
30882613
2.

Prevalence of mental illness in primary care and its association with deprivation and social fragmentation at the small-area level in England.

Grigoroglou C, Munford L, Webb RT, Kapur N, Ashcroft DM, Kontopantelis E.

Psychol Med. 2019 Feb 12:1-10. doi: 10.1017/S0033291719000023. [Epub ahead of print]

PMID:
30744718
3.

Exploring the human factors of prescribing errors in paediatric intensive care units.

Sutherland A, Ashcroft DM, Phipps DL.

Arch Dis Child. 2019 Feb 8. pii: archdischild-2018-315981. doi: 10.1136/archdischild-2018-315981. [Epub ahead of print]

PMID:
30737262
4.

Self harm attempt in the older population of the UK - Author's reply.

Morgan C, Chew-Graham CA, Kontopantelis E, Kapur N, Webb RT, Carr MJ, Ashcroft DM.

Lancet Psychiatry. 2019 Feb;6(2):92-93. doi: 10.1016/S2215-0366(19)30003-3. No abstract available.

PMID:
30686390
5.

Spatial distribution and temporal trends in social fragmentation in England, 2001-2011: a national study.

Grigoroglou C, Munford L, Webb RT, Kapur N, Ashcroft DM, Kontopantelis E.

BMJ Open. 2019 Jan 24;9(1):e025881. doi: 10.1136/bmjopen-2018-025881.

6.

Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic review.

Zghebi SS, Panagioti M, Rutter MK, Ashcroft DM, van Marwijk H, Salisbury C, Chew-Graham CA, Buchan I, Qureshi N, Peek N, Mallen C, Mamas M, Kontopantelis E.

Diabet Med. 2019 Jan 22. doi: 10.1111/dme.13905. [Epub ahead of print] Review.

PMID:
30672017
7.

Investigating the Agreement Between Cardiovascular Disease Risk Calculators Among People Diagnosed With Schizophrenia.

Berry A, Drake RJ, Webb RT, Ashcroft DM, Carr MJ, Yung AR.

Front Psychiatry. 2018 Dec 12;9:685. doi: 10.3389/fpsyt.2018.00685. eCollection 2018.

8.

Persistence and Effectiveness of Non-Biologic Systemic Therapies for Moderate-Severe Psoriasis in Adults: a Systematic Review.

Mason KJ, Williams S, Yiu ZZN, McElhone K, Ashcroft DM, Kleyn CE, Jabbar-Lopez ZK, Owen CM, Reynolds NJ, Smith CH, Wilson N, Warren RB, Griffiths CEM.

Br J Dermatol. 2019 Jan 10. doi: 10.1111/bjd.17625. [Epub ahead of print] Review.

PMID:
30628069
9.

Relationship between prescribing of antibiotics and other medicines in primary care: a cross-sectional study.

Li Y, Mölter A, White A, Welfare W, Palin V, Belmonte M, Ashcroft DM, Sperrin M, van Staa TP.

Br J Gen Pract. 2019 Jan;69(678):e42-e51. doi: 10.3399/bjgp18X700457. Epub 2018 Dec 17.

10.

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy.

Yiu ZZN, Sorbe C, Lunt M, Rustenbach SJ, Kühl L, Augustin M, Mason KJ, Ashcroft DM, Griffiths CEM, Warren RB; BADBIR Study Group.

Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17421. [Epub ahead of print]

PMID:
30430546
11.

SMASH! The Salford medication safety dashboard.

Williams R, Keers R, Gude WT, Jeffries M, Davies C, Brown B, Kontopantelis E, Avery AJ, Ashcroft DM, Peek N.

J Innov Health Inform. 2018 Oct 18;25(3):183-193. doi: 10.14236/jhi.v25i3.1015.

12.

Disparities in mortality among 25-44-year-olds in England: a longitudinal, population-based study.

Kontopantelis E, Buchan I, Webb RT, Ashcroft DM, Mamas MA, Doran T.

Lancet Public Health. 2018 Dec;3(12):e567-e575. doi: 10.1016/S2468-2667(18)30177-4. Epub 2018 Oct 31. Erratum in: Lancet Public Health. 2018 Dec;3(12):e566.

13.

What causes medication administration errors in a mental health hospital? A qualitative study with nursing staff.

Keers RN, Plácido M, Bennett K, Clayton K, Brown P, Ashcroft DM.

PLoS One. 2018 Oct 26;13(10):e0206233. doi: 10.1371/journal.pone.0206233. eCollection 2018.

14.

Developing a learning health system: Insights from a qualitative process evaluation of a pharmacist-led electronic audit and feedback intervention to improve medication safety in primary care.

Jeffries M, Keers RN, Phipps DL, Williams R, Brown B, Avery AJ, Peek N, Ashcroft DM.

PLoS One. 2018 Oct 26;13(10):e0205419. doi: 10.1371/journal.pone.0205419. eCollection 2018.

15.

Risk factors for self-harm in people with epilepsy.

Gorton HC, Webb RT, Pickrell WO, Carr MJ, Ashcroft DM.

J Neurol. 2018 Dec;265(12):3009-3016. doi: 10.1007/s00415-018-9094-2. Epub 2018 Oct 24.

16.

Self-harm in a primary care cohort of older people: incidence, clinical management, and risk of suicide and other causes of death.

Morgan C, Webb RT, Carr MJ, Kontopantelis E, Chew-Graham CA, Kapur N, Ashcroft DM.

Lancet Psychiatry. 2018 Nov;5(11):905-912. doi: 10.1016/S2215-0366(18)30348-1. Epub 2018 Oct 15.

17.

Organizational conditions for engagement in quality and safety improvement: a longitudinal qualitative study of community pharmacies.

Phipps DL, Jones CEL, Parker D, Ashcroft DM.

BMC Health Serv Res. 2018 Oct 17;18(1):783. doi: 10.1186/s12913-018-3607-7.

18.

The challenge of ageing populations and patient frailty: can primary care adapt?

Reeves D, Pye S, Ashcroft DM, Clegg A, Kontopantelis E, Blakeman T, van Marwijk H.

BMJ. 2018 Aug 28;362:k3349. doi: 10.1136/bmj.k3349. No abstract available.

19.

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group.

Br J Dermatol. 2019 Feb;180(2):329-337. doi: 10.1111/bjd.17036. Epub 2018 Oct 21.

PMID:
30070708
20.

Association between a national primary care pay-for-performance scheme and suicide rates in England: spatial cohort study.

Grigoroglou C, Munford L, Webb RT, Kapur N, Doran T, Ashcroft DM, Kontopantelis E.

Br J Psychiatry. 2018 Oct;213(4):600-608. doi: 10.1192/bjp.2018.143. Epub 2018 Jul 30.

PMID:
30058517
21.

Exploring medicines management by COPD patients and their social networks after hospital discharge.

Schafheutle EI, Fegan T, Ashcroft DM.

Int J Clin Pharm. 2018 Oct;40(5):1019-1029. doi: 10.1007/s11096-018-0688-7. Epub 2018 Jul 28.

22.

Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study.

Parisi R, Webb RT, Kleyn CE, Carr MJ, Kapur N, Griffiths CEM, Ashcroft DM.

Br J Dermatol. 2019 Jan;180(1):108-115. doi: 10.1111/bjd.17004. Epub 2018 Oct 10.

PMID:
30007069
23.

Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.

Zghebi SS, Rutter MK, Ashcroft DM, Salisbury C, Mallen C, Chew-Graham CA, Reeves D, van Marwijk H, Qureshi N, Weng S, Peek N, Planner C, Nowakowska M, Mamas M, Kontopantelis E.

BMJ Open. 2018 Jun 30;8(6):e020926. doi: 10.1136/bmjopen-2017-020926.

24.
25.

Understanding procedural violations using Safety-I and Safety-II: The case of community pharmacies.

Jones CEL, Phipps DL, Ashcroft DM.

Saf Sci. 2018 Jun;105:114-120. doi: 10.1016/j.ssci.2018.02.002.

26.

Hospital admissions associated with medication non-adherence: a systematic review of prospective observational studies.

Mongkhon P, Ashcroft DM, Scholfield CN, Kongkaew C.

BMJ Qual Saf. 2018 Nov;27(11):902-914. doi: 10.1136/bmjqs-2017-007453. Epub 2018 Apr 17.

PMID:
29666309
27.

Mindful organizing in patients' contributions to primary care medication safety.

Phipps DL, Giles S, Lewis PJ, Marsden KS, Salema N, Jeffries M, Avery AJ, Ashcroft DM.

Health Expect. 2018 Dec;21(6):964-972. doi: 10.1111/hex.12689. Epub 2018 Apr 14.

28.

Risk of Unnatural Mortality in People With Epilepsy.

Gorton HC, Webb RT, Carr MJ, DelPozo-Banos M, John A, Ashcroft DM.

JAMA Neurol. 2018 Aug 1;75(8):929-938. doi: 10.1001/jamaneurol.2018.0333.

PMID:
29630689
29.

Frequently used drug types and alcohol involvement in intentional drug overdoses in Ireland: a national registry study.

Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ, Arensman E.

Eur J Public Health. 2018 Aug 1;28(4):681-686. doi: 10.1093/eurpub/cky031.

PMID:
29538652
30.

Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study.

Kontopantelis E, Stevens RJ, Helms PJ, Edwards D, Doran T, Ashcroft DM.

BMJ Open. 2018 Feb 28;8(2):e020738. doi: 10.1136/bmjopen-2017-020738.

31.
32.

Negotiating inter-professional interaction: playing the general practitioner-pharmacist game.

Bradley F, Ashcroft DM, Crossley N.

Sociol Health Illn. 2018 Mar;40(3):426-444. doi: 10.1111/1467-9566.12656. Epub 2018 Jan 12.

PMID:
29327351
33.

Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015.

Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ, Arensman E.

Clin Drug Investig. 2018 Apr;38(4):373-380. doi: 10.1007/s40261-017-0616-y.

PMID:
29264838
34.

Geographical epidemiology of health and overall deprivation in England, its changes and persistence from 2004 to 2015: a longitudinal spatial population study.

Kontopantelis E, Mamas MA, van Marwijk H, Ryan AM, Buchan IE, Ashcroft DM, Doran T.

J Epidemiol Community Health. 2018 Feb;72(2):140-147. doi: 10.1136/jech-2017-209999. Epub 2017 Dec 20.

35.

Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients' Medication Beliefs and Habit Strength.

Thorneloe RJ, Griffiths CEM, Emsley R, Ashcroft DM, Cordingley L; British Association of Dermatologists Biologic Interventions Register; Psoriasis Stratification to Optimise Relevant Therapy Study Groups.

J Invest Dermatol. 2018 Apr;138(4):785-794. doi: 10.1016/j.jid.2017.11.015. Epub 2017 Nov 26.

36.

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Iskandar IYK, Warren RB, Lunt M, Mason KJ, Evans I, McElhone K, Smith CH, Reynolds NJ, Ashcroft DM, Griffiths CEM; BADBIR Study Group.

J Invest Dermatol. 2018 Apr;138(4):775-784. doi: 10.1016/j.jid.2017.09.044. Epub 2017 Dec 6.

37.

Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Yiu ZZN, Smith CH, Ashcroft DM, Lunt M, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group.

J Invest Dermatol. 2018 Mar;138(3):534-541. doi: 10.1016/j.jid.2017.10.005. Epub 2017 Oct 17.

38.

Incidence, clinical management, and mortality risk following self harm among children and adolescents: cohort study in primary care.

Morgan C, Webb RT, Carr MJ, Kontopantelis E, Green J, Chew-Graham CA, Kapur N, Ashcroft DM.

BMJ. 2017 Oct 18;359:j4351. doi: 10.1136/bmj.j4351.

39.

Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials': reply from the authors.

Rungapiromnan W, Yiu ZZN, Warren RB, Griffiths CEM, Ashcroft DM.

Br J Dermatol. 2017 Dec;177(6):1766-1767. doi: 10.1111/bjd.16043. Epub 2017 Nov 22. No abstract available.

PMID:
28990164
40.

Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study.

Parisi R, Webb RT, Carr MJ, Moriarty KJ, Kleyn CE, Griffiths CEM, Ashcroft DM.

JAMA Dermatol. 2017 Dec 1;153(12):1256-1262. doi: 10.1001/jamadermatol.2017.3225.

41.

Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review.

Alshehri GH, Keers RN, Ashcroft DM.

Drug Saf. 2017 Oct;40(10):871-886. doi: 10.1007/s40264-017-0557-7. Review.

PMID:
28776179
42.

The global state of psoriasis disease epidemiology: a workshop report.

Griffiths CEM, van der Walt JM, Ashcroft DM, Flohr C, Naldi L, Nijsten T, Augustin M.

Br J Dermatol. 2017 Jul;177(1):e4-e7. doi: 10.1111/bjd.15610. Epub 2017 May 28.

43.

Premature Death Among Primary Care Patients With a History of Self-Harm.

Carr MJ, Ashcroft DM, Kontopantelis E, While D, Awenat Y, Cooper J, Chew-Graham C, Kapur N, Webb RT.

Ann Fam Med. 2017 May;15(3):246-254. doi: 10.1370/afm.2054.

44.
45.

Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014.

Zghebi SS, Steinke DT, Carr MJ, Rutter MK, Emsley RA, Ashcroft DM.

Diabetes Obes Metab. 2017 Nov;19(11):1537-1545. doi: 10.1111/dom.12964. Epub 2017 Jul 5.

PMID:
28387052
46.

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis.

Iskandar IYK, Ashcroft DM, Warren RB, Lunt M, McElhone K, Smith CH, Reynolds NJ, Griffiths CEM.

Br J Dermatol. 2017 Nov;177(5):1410-1421. doi: 10.1111/bjd.15531. Epub 2017 Oct 19.

PMID:
28369707
47.

Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research Datalink.

Thompson A, Wright AK, Ashcroft DM, van Staa TP, Pirmohamed M.

PLoS One. 2017 Mar 31;12(3):e0174818. doi: 10.1371/journal.pone.0174818. eCollection 2017.

48.

Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.

Thompson A, Ashcroft DM, Owens L, van Staa TP, Pirmohamed M.

PLoS One. 2017 Mar 20;12(3):e0173272. doi: 10.1371/journal.pone.0173272. eCollection 2017.

49.

Understanding the implementation and adoption of a technological intervention to improve medication safety in primary care: a realist evaluation.

Jeffries M, Phipps DL, Howard RL, Avery AJ, Rodgers S, Ashcroft DM.

BMC Health Serv Res. 2017 Mar 14;17(1):196. doi: 10.1186/s12913-017-2131-5.

50.

Understanding the epidemiology of avoidable significant harm in primary care: protocol for a retrospective cross-sectional study.

Bell BG, Campbell S, Carson-Stevens A, Evans HP, Cooper A, Sheehan C, Rodgers S, Johnson C, Edwards A, Armstrong S, Mehta R, Chuter A, Donnelly A, Ashcroft DM, Lymn J, Smith P, Sheikh A, Boyd M, Avery AJ.

BMJ Open. 2017 Feb 17;7(2):e013786. doi: 10.1136/bmjopen-2016-013786. Erratum in: BMJ Open. 2017 Mar 16;7(3):e013786corr1.

Supplemental Content

Loading ...
Support Center